基于病毒样颗粒的疫苗用于对抗神经退行性疾病
Luis Wei Cheng Lim1, Jia Yee Lee1, Ching Hsein Chen2
1School of Health Science, International Medical University, 57000 Kuala Lumpur, Malaysia.
Current pharmaceutical biotechnology
|October 30, 2024
概括
病毒样颗粒 (VLP) 是一种新型免疫疗法,可用于治疗神经退行性疾病,如阿尔茨海默氏症和帕金森氏症. 这些安全的,非传染性疫苗在临床前模型中有效地准疾病病理.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 疫苗学 疫苗学 疫苗学
背景情况:
- 神经退行性疾病,包括阿尔茨海默病 (AD) 和帕金森病 (PD),是渐进的,目前无法治愈的.
- 现有的治疗方法只治疗症状,而不是潜在的病理.
- 新型疾病修饰疗法,如免疫疗法,对于有效治疗至关重要.
研究的目的:
- 审查针对神经退行性疾病的基于病毒样粒子 (VLP) 的疫苗的临床前和临床研究结果.
- 探索VLP作为活性免疫治疗方法的潜力.
- 为了解决VLP疫苗应用中的局限性和挑战.
主要方法:
- 临床前动物模型研究的汇编.
- 对基于VLP的疫苗的临床研究的审查.
- 分析VLP免疫性和安全性概况.
主要成果:
- 大型VLP表现出高免疫性,诱导幽默和细胞介导反应.
- 在动物模型中,VLPs有效地产生对Aβ,tau和α-Synuclein的抗体.
- VLPs避免了T细胞免疫反应,比传统疫苗提供了安全优势.
结论:
- 病毒样颗粒 (VLP) 是神经退行性疾病的有前途的活性免疫疗法策略.
- 基于VLP的疫苗在AD和PD的临床前模型中显示出有效性.
- 需要进一步的研究来克服临床应用的技术限制.
相关概念视频
siRNA - Small Interfering RNAs
16.6K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.6K
Microorganisms in Medicine and Therapeutics
1
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1
Parkinson's Disease: Overview
486
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
486


